Inotiv Inc reports results for the quarter ended September 30 - Earnings Summary

• Inotiv Inc NOTV.OQ reported a quarterly adjusted loss of 73 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -38 cents. The mean expectation of three analysts for the quarter was for a loss of 91 cents per share.

• Revenue fell 7.3% to $130.42 million from a year ago; analysts expected $116.94 million.

• Inotiv Inc's reported EPS for the quarter was a loss of 73 cents​.

• The company reported a quarterly loss of $18.89 million.

• Inotiv Inc shares had risen by 129.4% this quarter and gained 6.3% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Inotiv Inc is $4.00

This summary was machine generated from LSEG data December 3 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)